Anti-HIV weapons should be used to fight hepatitis C, researchers say
Tools developed to battle HIV infection in vulnerable populations such as intravenous drugs users should be focused on battling hepatitis C infection, according to the author of a study of street youth in Vancouver.
“We were shocked at how prevalent hepatitis C is in this population and really alarmed at the rates of transmission,” said lead author Dr. Scott Hadland, a researcher with the BC Centre for Excellence's Urban Health Research Initiative.
Randy Shore reports
Dr. Michael O'Shaughnessy